Alzheimer's disease is the most common form of dementia, affecting nearly 6 million Americans. Characterized by progressive memory loss, cognitive impairment, and personality changes, this neurodegenerative disorder has become a growing health concern as the nation's population ages.

Early detection can enable more timely treatments and interventions. Currently, doctors rely on several biomarkers to detect Alzheimer's disease. However, collecting biomarker data can be expensive and time-consuming.

The Penn State researchers will design a system that utilizes a variety of biosensors, including optical, mechanical, and electrochemical nano-sensors, to analyze biological samples. Such biosensing data pairs well with machine learning, and the combination of the two technologies could lead to discoveries about other diseases. The team is currently analyzing animal biological samples; if successful, they will transition to human samples.

"Given different types of sensing data, for instance, data acquired from different biochemical markers in human body fluids, machine learning can perform feature selection and establish associations between an individual biomarker and Alzheimer's disease," co-principal investigator Sharon Huang, PhD, Penn State professor of information sciences, said in a statement. "The technique also has the potential to be high throughput, making it possible to be used in screening for the disease."

"Our next steps are to develop more inexpensive and non-invasive diagnosis methods for Alzheimer's disease and incorporate more sensing data such as human vocal biomarkers and eye movement biomarkers," said lead principal investigator Fenglong Ma, PhD, Penn State assistant professor of information sciences.

Classifying macrophages via machine learning may help target disease
Trinity College Dublin researchers have developed a new machine learning-based technique to accurately classify the state of key immune cells called macrophages,...

Multiomics analysis reveals potential opportunity for early intervention in Alzheimer’s
A gene that carries a strong risk for Alzheimer’s disease drives changes in the brain’s blood vessels that lead to problems in synapses and ultimately...

Map of brain changes in Alzheimer’s reveals potential target cell for drug therapies
A National Institute of Aging-backed project has released large-scale cellular and molecular information taken from more than 1.2 million neurons and...

Tau PET reveals patterns of early Alzheimer's disease
Positron emission tomography (PET) scans in patients with early Alzheimer's disease reveal patterns of tau deposits that could help researchers improve...

Protein biosensors show promise for SARS-CoV-2 testing
Scientists have developed biosensors to detect SARS-CoV-2 proteins and antibodies in simulated nasal fluids and human sera, according to a study published...

Extracellular RNA identifies new Alzheimer's biomarker
The association of extracellular RNA with upregulation of the phosphoglycerate dehydrogenase gene may be a useful presymptomatic biomarker for Alzheimer's...